immunotherapy
Isticmaalka Immunotherapy si loogu daweeyo Kaansarka Marxaladda Dambe
Horudhac Immunotherapy waxa ay noqotay hab horudhac u ah daawaynta kansarka, gaar ahaan daawaynta kansarka heer-sare ee muujiyay waxtarka ugu yar ee daawooyinka caadiga ah. Appr-kan hal-abuurka leh
GARGAARKA GARGAARKA, Daaweynta CAR, immunotherapy, Daaweynta unugyada T
CAR T-Cell Therapy ma laga heli karaa Hindiya?
Weligaa ma is weydiisay inay jirto hab awood leh oo lagula dagaallamo kansarka? Bal qiyaas haddii aad maalin uun ka heshay rajada dagaalka aad kula jirto kansarka, daawaynta u adeegsata awoodda habka difaaca jidhkaaga si aad u beegsato
2 iyo todobaatan bio, Shiinaha, immunotherapy, Daawooyinka JW, Partnership
JW Therapeutics iyo 2 bio ayaa ku dhawaaqay iskaashiga istiraatijiyadeed si loo dardargeliyo cilmi baarista iyo horumarinta daawoyinka difaaca jirka ee T-cell
SHANGHAI, CHINA iyo CAMBRIDGE, MASSACHUSETTS, US, Oktoobar 27, 2022 - JW Therapeutics (HKEX: 2126), shirkad madax-bannaan oo hal-abuur leh bayotechnoolajiyada diiradda saaraya horumarinta, soo saarista, iyo ganacsiyaynta immunotherap unug.
BMS, Bristol Myers Squibb, immunotherapy, melanoma metastatic, nivolumab iyo relatlimab, nivolumab iyo relatlimab-rmbw, Opdualag, USFDA
Marka hore LAG-3-Blocking antibody isku darka, Opdualag™ (nivolumab iyo relatlimab-rmbw), waxa u ansixisay FDA bukaanada qaba melanoma aan la dabooli karin ama metastatic
Abriil 2022: Maamulka Cunnada iyo Dawooyinka ee Mareykanka (FDA) ayaa ansixiyay Opdualag (nivolumab iyo relatlimab-rmbw), cusub, fasalka koowaad-ku-jira qiyaas go'an oo isku darka nivolumab iyo relatlimab oo loo maamulo faleebo hal xidid xididka ah, f..
Culeyska burada oo sarreeya, immunotherapy, KEYTRUDA, Pembrolizumab, TMB-H
Pembrolizumab ayaa loo oggolaaday in loo isticmaalo kansar kasta oo leh culeys is -beddel buro
Julaay 2021: Maamulka Cunnada iyo Dawooyinka ee Maraykanka (FDA) waxa ay balaadhisay tilmaamaha pembrolizumab (Keytruda), oo ah dawada difaaca jirka, si ay u koobto kansar kasta oo leh culays is badal sare leh (TMB-H). Oggolaanshaha cusub waa f..
immunotherapy, Beerka, Singapore, Daaweynta
Singapore markii ugu horeysay waxay ansaxisay T cell engineering immunotherapy ee kansarka beerka
Ogosto 19, 2018: Shirkadda cilmiga bayoolajiga ee Singapore Lion TCR Pte. Ltd. waxaa ansixiyay Hay'adda Sayniska Caafimaadka ee Singapore (HSA), iyo badeecadeeda musharax (LioCyx ™) waxaa loo isticmaali karaa cilmi-baarista bukaan-socodka ee wajiga I / II ee daaweynta.
GAARI NK, immunotherapy
CAR daaweynta unugga dilaaga dabiiciga ah - MD Anderson wuxuu lashaqeeyaa Takeda
Jaamacadda Texas MD Anderson Cancer Center iyo Takeda Pharmaceutical Company Limited waxay galeen faham xaddidan iyo oggolaansho cilmi baaris si ay u horumariyaan oo ay u suuq geeyaan soo-dhoweynta antigen-ka ee hagaya dilaaga dabiiciga ah (CAR.
immunotherapy, Daaweynta dilaaga dabiiciga ah, Daaweynta unugyada NK
Daaweynta CAR-NK - Daaweynta cusub ee daaweynta kansarka
Daawaynta CAR-NK waa nooc cusub oo immunotherapy ah ee daawaynta kansarka. Immunotherapy waxay wax ka beddeshay habka loo daweeyo kansarka. Immunotherapy Kansarka waxa loo qaybiyaa laba qaybood: mid waa isbaarada difaaca oo ka hortagta.
Daroogooyinka, immunotherapy
Dawada tallaalka cusub ee kansarka
Isbaarada difaacu waa qayb dawooyin ah oo la dagaalama habka difaaca jidhka si ay ula dagaalamaan unugyada kansarka. Si kastaba ha ahaatee, bukaanada badankoodu kama jawaabaan daawayntan. Waxaa jira nooc cusub oo daroogo ah oo bartilmaameedsada laba pr..